|
| | CERIVASTATIN SODIUM Basic information |
| Product Name: | CERIVASTATIN SODIUM | | Synonyms: | RIVASTATIN;sodium 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-dipropan-2-yl-pyrid in-3-yl]-3,5-dihydroxy-hept-6-enoate;LIPOBAY;BAYCOL;CERIVASTATIN NA;CERIVASTATIN, SODIUM SALT;7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-dipropan-2-yl-pyrid in-3-yl]-3,5-dihydroxy-hept-6-enoate;(3R,5S,6E)-7-[4-(p-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-6-heptenoic acid | | CAS: | 145599-86-6 | | MF: | C26H34FNO5 | | MW: | 459.55 | | EINECS: | | | Product Categories: | Active Pharmaceutical Ingredients | | Mol File: | 145599-86-6.mol |  |
| | CERIVASTATIN SODIUM Chemical Properties |
| Melting point | >176oC (dec.) | | Boiling point | 646.3±55.0 °C(Predicted) | | density | 1.181±0.06 g/cm3(Predicted) | | storage temp. | Hygroscopic, -20°C Freezer, Under Inert Atmosphere | | solubility | Ethanol (Slightly), Methanol (Slightly), Water (Slightly) | | pka | pKa 4.38 (H2O t=25 I=0.025) (Uncertain);5.29(H2O t=25 I=0.025) (Uncertain) | | form | Solid | | color | White to Off-White | | Stability: | Hygroscopic | | CAS DataBase Reference | 145599-86-6(CAS DataBase Reference) | | EPA Substance Registry System | 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1- methylethyl)-3-pyridinyl]-3,5-dihydroxy-, (3R,5S,6E)- (145599-86-6) |
| | CERIVASTATIN SODIUM Usage And Synthesis |
| Uses | assimilate cholesterol | | Definition | ChEBI: (3R,5S)-3,5-dihydroxyhept-6-enoic acid in which the (7E)-hydrogen is substituted by a 4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)pyridin-3-yl group. Formerly used (as its sodium salt) to lower cho
esterol and prevent cardiovascular disease, it was withdrawn from the market worldwide in 2001 following reports of a severe form of muscle toxicity. | | Brand name | Baycol
(Bayer);Cholstat. |
| | CERIVASTATIN SODIUM Preparation Products And Raw materials |
|
